PIRSUE DIN 02264730
Status: Dormant
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | PIRLIMYCIN (PIRLIMYCIN HYDROCHLORIDE) 50 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramammary |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 22-Jun-2005 |
|---|
| Current status date | 13-Jul-2022 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PIRLIMYCIN (PIRLIMYCIN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02207753 | PIRSUE AQUEOUS GEL | PHARMACIA ANIMAL HEALTH | Gel | PIRLIMYCIN (PIRLIMYCIN HYDROCHLORIDE) 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 15167 | 2014-01-28 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 9940 | 2008-12-15 | Supplement to a New Drug Submission (SNDS) | Additional clinical claims |
| 6320 | 2005-03-07 | New Drug Submission (NDS) | |
Request a quote for PIRSUE
How to read a Canadian DIN record